| Image |
|
| GO Annotations |
Cellular Component |
|
| Molecular Function |
|
| Biological Process |
|
| Pathways |
|
| Drugs |
- Choline
- Tacrine
- Carbachol
- Dipivefrin
- Gallamine Triethiodide
- Pyridostigmine
- Galantamine
- Isoflurophate
- Pralidoxime
- Minaprine
- Donepezil
- Ranitidine
- Demecarium
- Physostigmine
- Rivastigmine
- Edrophonium
- Ambenonium
- Tubocurarine
- Metoclopramide
- Decamethonium
- Ephedrine
- Neostigmine
- Monoisopropylphosphorylserine
- Propidium
- 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium
- 3,6,9,12,15-Pentaoxaheptadecane
- 1-Deoxy-1-Thio-Heptaethylene Glycol
- (4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium
- Methylphosphonic Acid Ester Group
- Methylphosphinic Acid
- 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium
- Acetylcholine
- beta-L-fucose
- Huperzine B
- M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene
- N-acetyl-alpha-D-glucosamine
- 2-(N-Morpholino)-Ethanesulfonic Acid
- MF268
- 3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine
- 3-[(1s)-1-(Dimethylamino)Ethyl]Phenol
- (R)-tacrine(10)-hupyridone
- (S)-tacrine(10)-hupyridone
- TACRINE(8)-4-AMINOQUINOLINE
- (9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM
- Zanapezil
- Huperzine A
- Huperzine A
- Phenserine
- Huperzine-A
- 1-(2-nitrophenyl)-2,2,2-trifluoroethyl]-arsenocholine
- 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE
- 1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL
- 1S,3AS,8AS-TRIMETHYL-1-OXIDO-1,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL 2-ETHYLPHENYLCARBAMATE
- Methylthioninium
- 1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE
- 2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM
- Dimetacrine
|
| Diseases |
|
| GWAS |
- Bipolar disorder ( 31043756)
- Blood protein levels ( 30072576)
- Body mass index ( 29273807)
- Diastolic blood pressure ( 30578418)
- Heart rate ( 23583979)
- Heart rate increase in response to exercise ( 29497042)
- Heart rate response to recovery post exercise ( 29769521)
- Heart rate response to recovery post exercise (10 sec) ( 29497042)
- Heart rate response to recovery post exercise (20 sec) ( 29497042)
- Heart rate response to recovery post exercise (30 sec) ( 29497042)
- Heart rate response to recovery post exercise (40 sec) ( 29497042)
- Heart rate response to recovery post exercise (50 sec) ( 29497042)
- Heel bone mineral density ( 30598549)
- Nonunion in individuals with fractures ( 30680360)
- Plasminogen activator inhibitor type 1 levels (PAI-1) ( 22990020)
- Pulse pressure ( 27841878)
- Resting heart rate ( 27798624)
- Type 2 diabetes ( 21490949)
|
| Interacting Genes |
8 interacting genes:
APP
COL4A1
COLQ
EIF2D
HAND1
LAMA1
LAMB1
PRIMA1
|
| Entrez ID |
43 |
| HPRD ID |
00010 |
| Ensembl ID |
ENSG00000087085
|
| Uniprot IDs |
P22303
|
| PDB IDs |
1B41
1F8U
1PUV
1PUW
1VZJ
2CLJ
2X8B
3LII
4BDT
4EY4
4EY5
4EY6
4EY7
4EY8
4M0E
4M0F
4PQE
5FOQ
5FPQ
5HF5
5HF6
5HF8
5HF9
5HFA
6CQT
6CQU
6CQV
6CQW
6CQX
6CQY
6CQZ
6F25
6NEA
6O4W
6O4X
6O50
6O52
6O5R
6O5S
6O5V
6O66
6O69
|
| Enriched GO Terms of Interacting Partners? |
|
| Tagcloud ? |
|